✦ LIBER ✦

P-565 Phase II study of Fenretinide in patients with small cell lung cancer (SCLC) with progression after first- or second-line chemotherapy

✍ Scribed by Schneider, Bryan; Worden, Francis P.; Gadgeel, Shirish M.; Hodges, Collette M.; Parchment, Ralph E.; Zwiebel, James A.; Kraut, Michael J.; Kalemkerian, Gregory P.

Book ID: 118572260
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 178 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92532-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel in patients with non-small cel

Docetaxel in patients with non-small cell lung cancer relapsed or progressed after first-line chemotherapy

✍ Teixeira, E; Sotto-Mayor, R; Borges, M; Almodovar, T; Duro da Costa, J; Bugalho 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

199 Second line chemotherapy with ambamu

199 Second line chemotherapy with ambamustine in small cell lung cancer (SCLC): A phase II FONICAP trial

✍ Pennucci, M.C.; Ricci, S.; Comella, G.; Conte, P.F.; Ardizzoni, A.; Boni, L.; Fr 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Phase II study of paclitaxel as first li

Phase II study of paclitaxel as first line treatment for patients with extensive stage small cell lung cancer (SCLC)

✍ Langley, R.E.; Woll, P.J.; Davidson, N.; Libretti, V.; Smyth, J.F.; Schipper, R; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Accelerated CDE chemotherapy with GM-CSF

Accelerated CDE chemotherapy with GM-CSF in small cell lung cancer (SCLC) patients: A phase II study

✍ Ardizzoni, A.; Verturini, M.; Sertoli, M.R.; Mariani, G.L.; Pennucci, M.C.; van 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 192 KB

A phase II study of paclitaxel (P) and c

A phase II study of paclitaxel (P) and carboplatin (C) as second-line treatment in patients (PTS) with small-cell lung cancer (SCLC)

✍ Agelaki, S.; Agelidou, M.; Blazogiannakis, G.; Tsiafaki, X.; Palamidas, Th.; Kou 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Topotecan (Hycamtin™) in small cell lung

Topotecan (Hycamtin™) in small cell lung cancer (SCLC) after failure of first line therapy: Multicentre phase II study

✍ von Pawel, J.; Deplerre, A.; Hans, K.; Moro, D.; Clark, P.; Gatzerneier, U.; Pai 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 270 KB